During the past decade, Klinikum Esslingen conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Esslingen" #1 sponsor was "University of Ulm" with 8 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "AIO-Studien-gGmbH" with 4 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "German CLL Study Group" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Esslingen" #1 collaborator was "German Breast Group" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "ClinAssess GmbH" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Esslingen" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Acute Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (5 trials), "Breast Cancer" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Klinikum Esslingen" in a lesser frequency.

Most popular intervention types in "Klinikum Esslingen" are "Drug" (47 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cytarabine" (5 trials), "Gemcitabine" (5 trials), "Carboplatin" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Esslingen" are 57 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Esslingen". undefined are not yet recruiting, 15 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Klinikum Esslingen, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Esslingen, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Klinikum Esslingen has several departments that took part in Clinical trials: "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" - 5 trials, "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" - 4 trials